Managing heart failure in the long-term care setting: nurses' experiences in Ontario, Canada.

Nurs Res

Patricia H. Strachan, PhD, RN, is Associate Professor; and Sharon Kaasalainen, PhD, RN, is Associate Professor, School of Nursing, McMaster University, Hamilton, Ontario, Canada. Amy Horton, MN, RN(EC), is Nurse Practitioner-Primary Health Care, Tutor-Ontario Primary Health Care Nurse Practitioner Program, School of Nursing, McMaster University, Hamilton, Ontario, Canada. Hellen Jarman, RN(EC), BScN, MN, GNC(C), is Nurse Practitioner-Primary Health Care, Geriatric Medicine Consultation Service, ED/Community Outreach Program, St. Mary's General Hospital, Ontario, Canada. Teresa D'Elia, MA, is Project Coordinator, Institute for Work and Health, Toronto, Ontario, Canada. Mary-Lou Van Der Horst, RN, MScN, MBA, is Assistant Clinical Professor, School of Nursing, McMaster University, Project Consultant Seniors' Health, Conestoga College and University of Waterloo-Research Institute for Aging-Schlegel Villages, Kitchener, Ontario, Canada. Ian Newhouse, PhD, is Professor, School of Kinesiology, Director of the Centre for Education and Research in Aging and Health, Lakehead University, Thunder Bay, Ontario, Canada. Mary Lou Kelley, MSW, PhD, is Lakehead University Research Chair in Palliative Care Professor, School of Social Work and Northern Ontario School of Medicine, Lakehead University, Thunder Bay, Ontario, Canada. Carrie McAiney, PhD, is Associate Professor, Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, Ontario, Canada. Robert McKelvie, MD, PhD, FRCPC, is Professor, McMaster University and Hamilton Health Sciences, Hamilton, Ontario, Canada. George A. Heckman, MD, MSc, FRCPC, is Schlegel Research Chair for Geriatric Medicine, Associate Professor, Research Institute for Aging and School of Public Health and Health Systems, University of Waterloo, Ontario, Canada.

Published: November 2014

Background: Implementation of heart failure guidelines in long-term care (LTC) settings is challenging. Understanding the conditions of nursing practice can improve management, reduce suffering, and prevent hospital admission of LTC residents living with heart failure.

Objective: The aim of the study was to understand the experiences of LTC nurses managing care for residents with heart failure.

Methods: This was a descriptive qualitative study nested in Phase 2 of a three-phase mixed methods project designed to investigate barriers and solutions to implementing the Canadian Cardiovascular Society heart failure guidelines into LTC homes. Five focus groups totaling 33 nurses working in LTC settings in Ontario, Canada, were audiorecorded, then transcribed verbatim, and entered into NVivo9. A complex adaptive systems framework informed this analysis. Thematic content analysis was conducted by the research team. Triangulation, rigorous discussion, and a search for negative cases were conducted. Data were collected between May and July 2010.

Results: Nurses characterized their experiences managing heart failure in relation to many influences on their capacity for decision-making in LTC settings: (a) a reactive versus proactive approach to chronic illness; (b) ability to interpret heart failure signs, symptoms, and acuity; (c) compromised information flow; (d) access to resources; and (e) moral distress.

Discussion: Heart failure guideline implementation reflects multiple dynamic influences. Leadership that addresses these factors is required to optimize the conditions of heart failure care and related nursing practice.

Download full-text PDF

Source
http://dx.doi.org/10.1097/NNR.0000000000000049DOI Listing

Publication Analysis

Top Keywords

heart failure
28
ltc settings
12
managing heart
8
long-term care
8
ontario canada
8
heart
8
failure guidelines
8
nursing practice
8
failure
7
ltc
6

Similar Publications

Purpose Of Review: This review aims to explore the complex interplay between atrial functional mitral regurgitation (AFMR), atrial fibrillation (AF), and heart failure with preserved ejection fraction (HFpEF). The goal is to define these conditions, examine their underlying mechanisms, and discuss treatment perspectives, particularly addressing diagnostic challenges.

Recent Findings: Recent research highlights the rising prevalence of AFMR, now accounting for nearly one-third of significant mitral regurgitation cases.

View Article and Find Full Text PDF

Detecting Hemorrhagic Myocardial Infarction With 3.0-T CMR: Insights Into Spatial Manifestation, Time-Dependence, and Optimal Acquisitions.

JACC Cardiovasc Imaging

January 2025

Department of Radiology and Imaging Sciences and Krannert Cardiovascular Research Center, Indiana University School of Medicine, Indianapolis, Indiana, USA. Electronic address:

Background: Hemorrhagic myocardial infarction (hMI) can rapidly diminish the benefits of reperfusion therapy and direct the heart toward chronic heart failure. T2∗ cardiac magnetic resonance (CMR) is the reference standard for detecting hMI. However, the lack of clarity around the earliest time point for detection, time-dependent changes in hemorrhage volume, and the optimal methods for detection can limit the development of strategies to manage hMI.

View Article and Find Full Text PDF

Background: Implementation of semaglutide weight loss therapy has been challenging due to drug supply and cost, underscoring a need to identify those who derive the greatest absolute benefit.

Objectives: Allocation of semaglutide was modeled according to coronary artery calcium (CAC) among individuals without diabetes or established atherosclerotic cardiovascular disease (CVD).

Methods: In this analysis, 3,129 participants in the MESA (Multi-Ethnic Study of Atherosclerosis) without diabetes or clinical CVD met body mass index criteria for semaglutide and underwent CAC scoring on noncontrast cardiac computed tomography.

View Article and Find Full Text PDF

Cardiovascular Outcomes With Antidiabetic Drugs in People With Type 2 Diabetes and a Prior Stroke.

Mayo Clin Proc

January 2025

Department of Internal Medicine, Korea University Anam Hospital, Seoul, Republic of Korea; Department of Internal Medicine, Korea University College of Medicine, Seoul, Republic of Korea. Electronic address:

Objective: To assess the comparative effectiveness of sodium-glucose cotransporter 2 inhibitors (SGLT2i), thiazolidinediones (TZD), and dipeptidyl peptidase-4 inhibitors (DPP-4i) for the cardiorenal outcomes and mortality in individuals with type 2 diabetes and a prior stroke.

Patients And Methods: Using the Korean National Health Insurance Service database from 2014 to 2021, a new-user cohort was established through propensity score matching for SGLT2i, TZD, and DPP-4i. The primary outcomes were major adverse cardiovascular events (MACE), comprising myocardial infarction, ischemic stroke, and cardiovascular death.

View Article and Find Full Text PDF

Quantifying DNA Lesions and Circulating Free DNA: Diagnostic Marker for Electropathology and Clinical Stage of AF.

JACC Clin Electrophysiol

December 2024

Physiology, Amsterdam Cardiovascular Sciences, Heart Failure, and Arrhythmias, Amsterdam University Medical Center, location Vrije Universiteit Amsterdam, Amsterdam, the Netherlands. Electronic address:

Background: Atrial fibrillation (AF) persistence is associated with molecular remodeling that fuels electrical conduction abnormalities in atrial tissue. Previous research revealed DNA damage as a molecular driver of AF.

Objectives: This study sought to explore the diagnostic value of DNA damage in atrial tissue and blood samples as an indicator of the prevalence of electrical conduction abnormalities and stage of AF.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!